Sponsor

VA Greater Los Angeles Healthcare System

Clinical research sponsor

Published trials22
Recruiting shown4
Roles2
SourceClinicalTrials.gov

Clinical trials

22 shown
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate CancerNCT06706921 · lead sponsor · 2024-12-15
RECRUITING
PSMA PET Scan and mpMRI for Prostate Cancer DetectionNCT05820724 · lead sponsor · 2023-05-01
UNKNOWN
Dashboard Activated Services and Tele-Health for Heart FailureNCT05001165 · lead sponsor · 2021-09-17
COMPLETED
18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate CancerNCT04390880 · lead sponsor · 2020-04-07
COMPLETED
Transcranial Direct Current Stimulation and Effects on Early Auditory Processing in SchizophreniaNCT03537703 · lead sponsor · 2018-05-20
COMPLETED
Stereotactic Body Radiotherapy (SBRT) for Localized Prostate CancerNCT04489745 · lead sponsor · 2016-12-01
UNKNOWN
Target Engagement of the Early Auditory Processing Network by Transcranial Direct Current Stimulation (tDCS)NCT02620267 · lead sponsor · 2015-12-15
COMPLETED
Curcumin as a Novel Treatment to Improve Cognitive Dysfunction in SchizophreniaNCT02104752 · lead sponsor · 2014-07-01
COMPLETED
N-acetylcysteine (NAC) for Improving Cognitive Dysfunction in SchizophreniaNCT01885338 · lead sponsor · 2013-06-01
COMPLETED
Pharmacological Approach to Improve the Outcome of Social Cognition TrainingNCT01517360 · lead sponsor · 2012-01-01
COMPLETED
Does Acute Oxytocin Administration Enhance Social Cognition in Individuals With Schizophrenia?NCT01312272 · lead sponsor · 2011-04-01
COMPLETED
Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney DiseaseNCT02476526 · lead sponsor · 2008-09-01
COMPLETED
Tolerability of Metoprolol-Succinate-ER and Carvedilol in COPDNCT03370835 · lead sponsor · 2004-06-01
COMPLETED
EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung CancerNCT05467748 · collaborator · 2025-12-08
RECRUITING
A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and CaregiversNCT05452031 · collaborator · 2022-11-09
RECRUITING
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.NCT05422911 · collaborator · 2022-08-31
RECRUITING
Assessing an EEG Biomarker of Response to TMS for Major DepressionNCT05008198 · collaborator · 2021-08-19
ACTIVE_NOT_RECRUITING
A Pharmaco-imaging Approach to Predicting Social Functioning and Clinical Responses to Oxytocin Administration in SchizophreniaNCT03900754 · collaborator · 2020-01-13
TERMINATED
High-quality COPD Care for People With Immune Dysfunction Through Proactive E-consultsNCT03856879 · collaborator · 2019-05-21
COMPLETED
Treatment of Social Cognition in Schizophrenia TrialNCT02246426 · collaborator · 2015-03-01
COMPLETED
Medications for Chronic HIV: Education and CollaborationNCT01038076 · collaborator · 2009-12-01
COMPLETED
Atkins Diet and Prostate Cancer Clinical TrialNCT00932672 · collaborator · 2009-06-01
TERMINATED

Sponsor roles

lead sponsor13
collaborator9

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.